Oli Case

Postpartum hemorrhage (PPH) is the leading cause of preventable maternal death. Oli PPH is an AI-guided medical device that identifies women at high risk of this condition before they ever give birth, offering awareness that can help prevent it from occurring. Oli PPH was granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). Baymatob, an Australian-based company and maker of Oli PPH, engaged Jump Simulation to understand how U.S. providers could effectively integrate this device into their clinical workflows.

Approach

Most of the work done through Jump Simulation centers around training health care professionals using simulated experiences. In this instance, the goal was to simulate an experience that fosters reflection on real-world behavior rather than skill development.

The simulation included six scenarios involving two teams, one from a rural hospital and one from an urban hospital. Both teams received information on the device ahead of the simulation and participated in an initial briefing. The first scenario included the application of the device, while the remaining scenarios simulated decision-making processes for assessing and managing postpartum hemorrhage.

Debriefing after each scenario was key to collecting the information needed to understand clinical behavior. The debriefing questions focused on evaluating current postpartum hemorrhage risk assessment and response processes, comparing them to the Oli system. The questions covered topics such as identifying high-risk patients, team communication, billing considerations, medication administration, mechanical interventions and blood transfusion protocols. Additionally, they explored the implementation of the Oli PPH device, including adoption challenges, workflow integration and team training.

Outcomes

For Baymatob, the simulation allowed them a unique opportunity to test their assumptions and obtain objective, tangible evidence of how their device could be integrated into labor and delivery workflows. Since Oli had never been used by U.S.-based clinicians, the simulation allowed Baymatob to identify the similarities and differences in its application compared to Australian clinical settings. This was valuable in ensuring their system is adaptable to a variety of clinical settings. The simulation also identified trends between the teams that showed how Oli PPH could impact clinician preparedness. These insights could have direct implications for improving health outcomes and determining costs for payers and hospitals.

Significance

Traditional health care simulation focuses on improving clinical behavior like procedural skills or decision-making. This simulation was unique because it centered on understanding behavior rather than changing it. By immersing clinicians in real-world scenarios with Oli PPH, the study captured how providers respond to postpartum hemorrhage and how new technology might integrate into existing workflows. This approach allows for a deeper exploration of adoption challenges that can impact the successful implementation of innovative medical devices.